Viewing Study NCT00253903


Ignite Creation Date: 2025-12-24 @ 7:16 PM
Ignite Modification Date: 2026-01-04 @ 4:14 PM
Study NCT ID: NCT00253903
Status: COMPLETED
Last Update Posted: 2010-11-30
First Post: 2005-11-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year
Sponsor: Sanofi
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: LTE6262
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: ICD Study Director
Old Organization: sanofi-aventis

Collaborators